Influenza virus vaccine (Dynavax)

N/A

Report date: 2022/03/22 09:09:43

Base Information

Drug NameInfluenza virus vaccine (Dynavax)

Drug Alias NameUniversal flu vaccine (M2e/NP-ISS + trivalent influenza vaccine) - DynavaxUniversal flu vaccine - DynavaxUniversal flu vaccineMe2 ISS + NP ISSN-8295

ClassificationVaccines > Biological material > Viral vaccineVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Inactivated vaccine > Subunit vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsInfluenza, Human

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPending (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesDynavax Gmbh

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesDynavax Gmbh

Active IndicationsN/A

Inactive IndicationsInfluenza, Human

Other Information

ATC CodeN/A